ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Metal-coordinated nanomedicine for combined tumor therapy by inducing paraptosis and apoptosis

Zheng, Rongrong; Zhao, Linping; Chen, Xiayun; Liu, Lingshan; Liu, Yibin; Chen, Xiantong; Wang, Chang; Yu, Xiyong; Cheng, Hong*; Li, Shiying*广州医学院; 南方医科大学; 5
Journal of Controlled Release2021-8-10DOI: 10.1016/j.jconrel.2021.06.021
17被引6阅读
引用收藏
分享

摘要

Apoptosis resistance of tumor cells often results in chemoresistance and treatment failure in clinic. In this work, a Cu2+-coordinated morusin/doxorubicin biological organizer (designated as COMBO) is designed to combat cellular resistance to apoptosis for combined tumor therapy. By virtue of the coordination and 7C-7C stacking effects, the self-assembled COMBO possesses nanometer particle size, narrow and homogenous graininess distribution as well as a good dispersion stability. Moreover, COMBO could be disassembled by glutathione (GSH) with an effective drug release and fluorescence recovery. Morusin-mediated paraptosis could induce extensive vacuolization through the dilation of endoplasmic reticulum (ER) and mitochondria, leading to non-apoptotic programmed cell death (PCD) regardless of the cellular resistance to apoptosis. Furthermore, the released doxorubicin prefers to locate in cell nucleus to cause cell apoptosis for combined chemotherapy. By the joint action of paraptosis and apoptosis, COMBO exhibits a great superiority over monotherapy in tumor inhibition with a low system toxicity. This study may open a window in the development of self-delivery nanomedicine for overcoming apoptosis resistance in tumor therapy.

学科与关键词

关键词
Self-deliveryGSH responsiveParaptosisApoptosisVacuolization
相关
加载中…
  • Carrier free nanomedicine for synergistic cancer therapy by initiating apoptosis and paraptosis
    Zheng, Rongrong; Liu, Yibin; Yu, Baixue; Zhao, Linping; Yang, Ni; Chen, Ali; Xu, Lin; Cheng, Hong*; Jiang, Xueyan*; Li, Shiying*Journal of Colloid and Interface Science, 2022, 622: 298-308.被引 5
  • Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition
    Zheng, Rong-Rong; Zhao, Lin-Ping; Huang, Chu-Yu; Cheng, Hong; Yang, Ni; Chen, Zu-Xiao; Cai, Hua; Zhang, Wei; Kong, Ren-Jiang; Li, Shi-Ying*ACS Nano, 2023, 17(11): 9972-9986.被引 7
  • Self-delivery nanomedicine to overcome drug resistance for synergistic chemotherapy?
    Zheng, Rong-Rong; Zhao, Lin-Ping; Liu, Ling-Shan; Deng, Fu-An; Chen, Xia-Yun; Jiang, Xue-Yan; Wang, Chang; Yu, Xi-Yong*; Cheng, Hong*; Li, Shi-Ying*Biomaterials Science, 2021, 9(9): 3445-3452.被引 18
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Controlled Release
发表日期
2021-08-10
卷期
第 336 卷
页码
159-168
DOI
10.1016/j.jconrel.2021.06.021
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [51803086, 52073140, 51802049, 21907018]; Guangdong Basic and Applied Basic Research Foundation [2021A1515010418, 2021B1515020043]; Science and Technology Programs of Guangzhou [201904010324, 202002030178]; Young Elite Scientist Sponsorship Program by CAST [2018QNRC001]; High-level University Construction Fund of Guangdong Province [06-410-2107205]

作者

  • Z

    Zheng, Rongrong (第一作者)

    guangzhou med univ · 5

  • Z

    Zhao, Linping

    guangzhou med univ · 5

查看全部 10 位作者收起作者
  • C

    Chen, Xiayun

    guangzhou med univ · 5

  • L

    Liu, Lingshan

    southern med univ

  • L

    Liu, Yibin

    guangzhou med univ · 5

  • C

    Chen, Xiantong

    guangzhou med univ · 5

  • W

    Wang, Chang

    guangzhou med univ · 5

  • Y

    Yu, Xiyong

    guangzhou med univ · 5

  • C

    Cheng, Hong (通讯)

    southern med univ

  • L

    Li, Shiying (通讯)

    guangzhou med univ · 5

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417